412 related articles for article (PubMed ID: 12826041)
1. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
Blazeby JM; Conroy T; Hammerlid E; Fayers P; Sezer O; Koller M; Arraras J; Bottomley A; Vickery CW; Etienne PL; Alderson D;
Eur J Cancer; 2003 Jul; 39(10):1384-94. PubMed ID: 12826041
[TBL] [Abstract][Full Text] [Related]
2. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
Hesari AE; Lari MA; Shandiz FH
Asian Pac J Cancer Prev; 2014; 15(6):2739-45. PubMed ID: 24761894
[TBL] [Abstract][Full Text] [Related]
3. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
[TBL] [Abstract][Full Text] [Related]
4. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
[TBL] [Abstract][Full Text] [Related]
5. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
6. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers.
Oñate-Ocaña LF; Velázquez-Monroy N; Vázquez L; Espinosa-Mireles-de-Villafranca P; Núñez-Rosas E; Ovando-Lezama M; Vilar-Compte D; García-Hubard G; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
Psychooncology; 2012 Jul; 21(7):745-53. PubMed ID: 21538681
[TBL] [Abstract][Full Text] [Related]
7. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer.
Greimel E; Bottomley A; Cull A; Waldenstrom AC; Arraras J; Chauvenet L; Holzner B; Kuljanic K; Lebrec J; D'haese S;
Eur J Cancer; 2003 Jul; 39(10):1402-8. PubMed ID: 12826043
[TBL] [Abstract][Full Text] [Related]
8. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
Whistance RN; Conroy T; Chie W; Costantini A; Sezer O; Koller M; Johnson CD; Pilkington SA; Arraras J; Ben-Josef E; Pullyblank AM; Fayers P; Blazeby JM;
Eur J Cancer; 2009 Nov; 45(17):3017-26. PubMed ID: 19765978
[TBL] [Abstract][Full Text] [Related]
9. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.
Blazeby JM; Alderson D; Winstone K; Steyn R; Hammerlid E; Arraras J; Farndon JR
Eur J Cancer; 1996 Oct; 32A(11):1912-7. PubMed ID: 8943674
[TBL] [Abstract][Full Text] [Related]
10. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
12. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18).
Mikoshiba N; Tateishi R; Tanaka M; Sakai T; Blazeby JM; Kokudo N; Koike K; Kazuma K
Health Qual Life Outcomes; 2012 May; 10():58. PubMed ID: 22651810
[TBL] [Abstract][Full Text] [Related]
15. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
16. A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer.
Sanna B; Bereza K; Paradowska D; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Golec J; Bottomley A; Tomaszewski KA
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28497549
[TBL] [Abstract][Full Text] [Related]
17. Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
Dai Z; Lang W; Yang H; Tian J; Sun W; Pekbay B; Lin Y; Wang M; Cui B; Yang S; Li H; Luo L; Guo H; Zhang L
Dis Esophagus; 2017 Oct; 30(10):1-7. PubMed ID: 28859386
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
[TBL] [Abstract][Full Text] [Related]
19. Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).
Stukan M; Zalewski K; Mardas M; Filarska D; Szajewski M; Kmieć A; Bińkowska P; Pietrzak-Stukan M; Dudziak M; Grabowski JP; Eskander RN; Greimel E
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28058740
[TBL] [Abstract][Full Text] [Related]
20. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
